In The News

Embr Labs Secures $35 Million to Fund Market Expansion

BOSTON, May 3, 2023 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading wearable to treat the symptoms of menopause, today announced that it has raised $35 million via intellectual property (IP)-based debt financing. Led by GT Investment Partners ("Ghost...

Embr Labs Secures $35 Million to Fund Market Expansion

BOSTON, May 3, 2023 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading wearable to treat the symptoms of menopause, today announced that it has raised $35 million via intellectual property (IP)-based debt financing. Led by GT Investment Partners ("Ghost...

Embr Labs Secures $35 Million to Fund Market Expansion

BOSTON, May 3, 2023 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading wearable to treat the symptoms of menopause, today announced that it has raised $35 million via intellectual property (IP)-based debt financing. Led by GT Investment Partners ("Ghost...

Safar Partners is committed to funding technological advances that create value.

 

Interested in partnering with us?

Contact Information

Safar Partners
One Broadway, 14th floor, 
Cambridge, MA 02142